{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:53:42Z","timestamp":1792072422122,"version":"4.4.0"},"reference-count":65,"publisher":"American Diabetes Association","issue":"11","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:p>An increasing number of studies suggest that the renal proximal tubule is a site of injury in diabetic nephropathy (DN), and progressive renal tubulointerstitial fibrosis is an important mediator of progressive kidney dysfunction in DN. In this study, we observed increased expression and activation of YAP (yes-associated protein) in renal proximal tubule epithelial cells (RPTC) in patients with diabetes and in mouse kidneys. Inducible deletion of Yap specifically in RPTC or administration of the YAP inhibitor verteporfin significantly attenuated diabetic tubulointerstitial fibrosis. EGFR-dependent activation of RhoA\/Rock and PI3K-Akt signals and their reciprocal interaction were upstream of proximal tubule YAP activation in diabetic kidneys. Production and release of CTGF in culture medium were significantly augmented in human embryonic kidney (HEK)-293 cells transfected with a constitutively active YAP mutant, and the conditioned medium collected from these cells activated and transduced fibroblasts into myofibroblasts. This study demonstrates that proximal tubule YAP-dependent paracrine mechanisms play an important role in diabetic interstitial fibrogenesis; therefore, targeting Hippo signaling may be a therapeutic strategy to prevent the development and progression of diabetic interstitial fibrogenesis.<\/jats:p>","DOI":"10.2337\/db20-0579","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T23:25:13Z","timestamp":1598397913000},"page":"2446-2457","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":112,"title":["YAP Activation in Renal Proximal Tubule Cells Drives Diabetic Renal Interstitial Fibrogenesis"],"prefix":"10.2337","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9438-1638","authenticated-orcid":false,"given":"Jianchun","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Veterans Affairs, Nashville, TN"},{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN"},{"name":"Vanderbilt Center for Kidney Disease, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Bulus","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes B.","family":"Fogo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN"},{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Zhi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN"},{"name":"Vanderbilt Center for Kidney Disease, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8025-0883","authenticated-orcid":false,"given":"Raymond C.","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Veterans Affairs, Nashville, TN"},{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN"},{"name":"Vanderbilt Center for Kidney Disease, Nashville, TN"},{"name":"Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"2022031303362867300_B1","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/jcm4061207","article-title":"The concept and the epidemiology of diabetic nephropathy have changed in recent years","volume":"4","author":"Mart\u00ednez-Castelao","year":"2015","journal-title":"J Clin Med"},{"key":"2022031303362867300_B2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ki.2009.509","article-title":"Diabetic kidney disease: act now or pay later","volume":"77","author":"Atkins","year":"2010","journal-title":"Kidney Int"},{"key":"2022031303362867300_B3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.semnephrol.2012.07.008","article-title":"Can we target tubular damage to prevent renal function decline in diabetes","volume":"32","author":"Bonventre","year":"2012","journal-title":"Semin Nephrol"},{"key":"2022031303362867300_B4","doi-asserted-by":"crossref","first-page":"F145","DOI":"10.1152\/ajprenal.00164.2016","article-title":"The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction","volume":"311","author":"Chevalier","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022031303362867300_B5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/adc.60.10.929","article-title":"Tubular dysfunction in type I diabetes mellitus","volume":"60","author":"Milt\u00e9nyi","year":"1985","journal-title":"Arch Dis Child"},{"key":"2022031303362867300_B6","first-page":"39","article-title":"Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosis","volume-title":"Kidney Int Suppl (2011)","author":"Bonventre","year":"2014"},{"key":"2022031303362867300_B7","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.2174\/0929867322666150625095407","article-title":"Insights into the mechanisms involved in the expression and regulation of extracellular matrix proteins in diabetic nephropathy","volume":"22","author":"Hu","year":"2015","journal-title":"Curr Med Chem"},{"key":"2022031303362867300_B8","doi-asserted-by":"crossref","first-page":"F733","DOI":"10.1152\/ajprenal.00212.2012","article-title":"Collagen VIII influences epithelial phenotypic changes in experimental diabetic nephropathy","volume":"303","author":"Loeffler","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022031303362867300_B9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-7-4","article-title":"The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis","volume":"7","author":"Genovese","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"key":"2022031303362867300_B10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrneph.2014.246","article-title":"Diverse origins of the myofibroblast\u2014implications for kidney fibrosis","volume":"11","author":"Falke","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"2022031303362867300_B11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3390\/cells4040631","article-title":"Epithelial-to-mesenchymal transition in diabetic nephropathy: fact or fiction","volume":"4","author":"Loeffler","year":"2015","journal-title":"Cells"},{"key":"2022031303362867300_B12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat Med"},{"key":"2022031303362867300_B13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.ki.5002180","article-title":"Phenotypic transitions and fibrosis in diabetic nephropathy","volume":"71","author":"Simonson","year":"2007","journal-title":"Kidney Int"},{"key":"2022031303362867300_B14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","article-title":"The biology of YAP\/TAZ: hippo signaling and beyond","volume":"94","author":"Piccolo","year":"2014","journal-title":"Physiol Rev"},{"key":"2022031303362867300_B15","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1074\/jbc.270.24.14733","article-title":"Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain","volume":"270","author":"Sudol","year":"1995","journal-title":"J Biol Chem"},{"key":"2022031303362867300_B16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/382646a0","article-title":"Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide","volume":"382","author":"Macias","year":"1996","journal-title":"Nature"},{"key":"2022031303362867300_B17","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.3390\/ijms19113674","article-title":"YAP\/TAZ signaling as a molecular link between fibrosis and cancer","volume":"19","author":"Noguchi","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2022031303362867300_B18","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1681\/ASN.2015050499","article-title":"YAP\/TAZ are mechanoregulators of TGF-\u03b2-Smad signaling and renal fibrogenesis","volume":"27","author":"Szeto","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2022031303362867300_B19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/CS20150385","article-title":"Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector","volume":"130","author":"Xu","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"2022031303362867300_B20","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1681\/ASN.2016060611","article-title":"Lats1\/2 regulate Yap\/Taz to control nephron progenitor epithelialization and inhibit myofibroblast formation","volume":"28","author":"McNeill","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2022031303362867300_B21","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1096\/fj.201900325R","article-title":"Src-mediated crosstalk between FXR and YAP protects against renal fibrosis","volume":"33","author":"Kim","year":"2019","journal-title":"FASEB J"},{"key":"2022031303362867300_B22","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1681\/ASN.2019101052","article-title":"Tubule-specific Mst1\/2 deficiency induces CKD via YAP and non-YAP mechanisms","volume":"31","author":"Xu","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2022031303362867300_B23","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2015040415","article-title":"Interaction of the EGF receptor and the Hippo pathway in the diabetic kidney","volume":"27","author":"Chen","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2022031303362867300_B24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/FJC.0b013e318070d1bd","article-title":"Rho kinase (ROCK) inhibitors","volume":"50","author":"Liao","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"2022031303362867300_B25","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.4161\/cc.21088","article-title":"Cell cycle regulation of Rho signaling pathways","volume":"11","author":"David","year":"2012","journal-title":"Cell Cycle"},{"key":"2022031303362867300_B26","first-page":"F180","article-title":"Subcellular distribution and membrane association of Rho-related small GTP-binding proteins in kidney cortex","volume":"269","author":"Boivin","year":"1995","journal-title":"Am J Physiol"},{"key":"2022031303362867300_B27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bcp.12196","article-title":"Rho kinase inhibition in diabetic kidney disease","volume":"76","author":"Komers","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"2022031303362867300_B28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1677\/JOE-06-0045","article-title":"A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats","volume":"192","author":"Kikuchi","year":"2007","journal-title":"J Endocrinol"},{"key":"2022031303362867300_B29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mce.2013.01.007","article-title":"Activation of RhoA\/ROCK regulates NF-\u03baB signaling pathway in experimental diabetic nephropathy","volume":"369","author":"Xie","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"2022031303362867300_B30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/bies.201200163","article-title":"G protein-coupled receptors engage the mammalian Hippo pathway through F-actin: F-Actin, assembled in response to Galpha12\/13 induced RhoA-GTP, promotes dephosphorylation and activation of the YAP oncogene","volume":"35","author":"Regu\u00e9","year":"2013","journal-title":"BioEssays"},{"key":"2022031303362867300_B31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.315127.118","article-title":"A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease","volume":"32","author":"Cai","year":"2018","journal-title":"Genes Dev"},{"key":"2022031303362867300_B32","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1681\/ASN.2017121272","article-title":"EGF receptor-dependent YAP activation is important for renal recovery from AKI","volume":"29","author":"Chen","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2022031303362867300_B33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1681\/ASN.2011070645","article-title":"EGFR signaling promotes TGF\u03b2-dependent renal fibrosis","volume":"23","author":"Chen","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2022031303362867300_B34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2014020192","article-title":"EGF receptor deletion in podocytes attenuates diabetic nephropathy","volume":"26","author":"Chen","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2022031303362867300_B35","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/emboj\/18.9.2551","article-title":"A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator","volume":"18","author":"Yagi","year":"1999","journal-title":"EMBO J"},{"key":"2022031303362867300_B36","doi-asserted-by":"crossref","first-page":"15164","DOI":"10.1074\/jbc.M010484200","article-title":"Physical interaction with Yes-associated protein enhances p73 transcriptional activity","volume":"276","author":"Strano","year":"2001","journal-title":"J Biol Chem"},{"key":"2022031303362867300_B37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4161\/cbt.6.6.4241","article-title":"The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation","volume":"6","author":"Vitolo","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"2022031303362867300_B38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.yexcr.2003.12.002","article-title":"Ligand-regulated association of ErbB-4 to the transcriptional co-activator YAP65 controls transcription at the nuclear level","volume":"294","author":"Omerovic","year":"2004","journal-title":"Exp Cell Res"},{"key":"2022031303362867300_B39","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1101\/gad.888601","article-title":"TEAD\/TEF transcription factors utilize the activation domain of YAP65, a Src\/Yes-associated protein localized in the cytoplasm","volume":"15","author":"Vassilev","year":"2001","journal-title":"Genes Dev"},{"key":"2022031303362867300_B40","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/db13-1279","article-title":"Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy","volume":"63","author":"Zhang","year":"2014","journal-title":"Diabetes"},{"key":"2022031303362867300_B41","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2353\/ajpath.2007.060481","article-title":"Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice","volume":"170","author":"Kanetsuna","year":"2007","journal-title":"Am J Pathol"},{"key":"2022031303362867300_B42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev-pathol-020712-163930","article-title":"Host responses in tissue repair and fibrosis","volume":"8","author":"Duffield","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"2022031303362867300_B43","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: one function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am J Pathol"},{"key":"2022031303362867300_B44","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","author":"Zhao","year":"2007","journal-title":"Genes Dev"},{"key":"2022031303362867300_B45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.2015.51","article-title":"Renal fibrosis is not reduced by blocking transforming growth factor-\u03b2 signaling in matrix-producing interstitial cells","volume":"88","author":"Neelisetty","year":"2015","journal-title":"Kidney Int"},{"key":"2022031303362867300_B46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(03)15172-0","article-title":"CCN proteins: multifunctional signalling regulators","volume":"363","author":"Perbal","year":"2004","journal-title":"Lancet"},{"key":"2022031303362867300_B47","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrneph.2014.184","article-title":"Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease","volume":"10","author":"Kok","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"2022031303362867300_B48","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cell.2013.07.042","article-title":"A mechanical checkpoint controls multicellular growth through YAP\/TAZ regulation by actin-processing factors","volume":"154","author":"Aragona","year":"2013","journal-title":"Cell"},{"key":"2022031303362867300_B49","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/ncb2756","article-title":"Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts","volume":"15","author":"Calvo","year":"2013","journal-title":"Nat Cell Biol"},{"key":"2022031303362867300_B50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10137","article-title":"Role of YAP\/TAZ in mechanotransduction","volume":"474","author":"Dupont","year":"2011","journal-title":"Nature"},{"key":"2022031303362867300_B51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(92)90163-7","article-title":"The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors","volume":"70","author":"Ridley","year":"1992","journal-title":"Cell"},{"key":"2022031303362867300_B52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.cellbio.21.020604.150721","article-title":"Rho GTPases: biochemistry and biology","volume":"21","author":"Jaffe","year":"2005","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2022031303362867300_B53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/cm.20472","article-title":"Rho-kinase\/ROCK: a key regulator of the cytoskeleton and cell polarity","volume":"67","author":"Amano","year":"2010","journal-title":"Cytoskeleton (Hoboken)"},{"key":"2022031303362867300_B54","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gad.192856.112","article-title":"Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP","volume":"26","author":"Liu-Chittenden","year":"2012","journal-title":"Genes Dev"},{"key":"2022031303362867300_B55","doi-asserted-by":"crossref","first-page":"42595","DOI":"10.1038\/srep42595","article-title":"TAZ contributes to pulmonary fibrosis by activating profibrotic functions of lung fibroblasts","volume":"7","author":"Noguchi","year":"2017","journal-title":"Sci Rep"},{"key":"2022031303362867300_B56","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","article-title":"The Hippo pathway effector YAP controls mouse hepatic stellate cell activation","volume":"63","author":"Mannaerts","year":"2015","journal-title":"J Hepatol"},{"key":"2022031303362867300_B57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jid.2017.08.024","article-title":"Therapeutic targeting of TAZ and YAP by dimethyl fumarate in systemic sclerosis fibrosis","volume":"138","author":"Toyama","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2022031303362867300_B58","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature24045","article-title":"Hippo pathway deficiency reverses systolic heart failure after infarction","volume":"550","author":"Leach","year":"2017","journal-title":"Nature"},{"key":"2022031303362867300_B59","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1681\/ASN.2015121354","article-title":"Yap\/Taz deletion in Gli+ cell-derived myofibroblasts attenuates fibrosis","volume":"28","author":"Liang","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2022031303362867300_B60","doi-asserted-by":"crossref","first-page":"e00565-16","DOI":"10.1128\/MCB.00565-16","article-title":"Sav1 loss induces senescence and Stat3 activation coinciding with tubulointerstitial fibrosis","volume":"37","author":"Leung","year":"2017","journal-title":"Mol Cell Biol"},{"key":"2022031303362867300_B61","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","volume":"22","author":"Zhao","year":"2008","journal-title":"Genes Dev"},{"key":"2022031303362867300_B62","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/dc07-2469","article-title":"Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy","volume":"31","author":"Nguyen","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031303362867300_B63","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1523-1755.2003.00130.x","article-title":"Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report","volume":"64","author":"Riser","year":"2003","journal-title":"Kidney Int"},{"key":"2022031303362867300_B64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/1354750X.2011.561366","article-title":"Connective tissue growth factor (CTGF\/CCN2) ELISA: a novel tool for monitoring fibrosis","volume":"16","author":"Dendooven","year":"2011","journal-title":"Biomarkers"},{"key":"2022031303362867300_B65","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/MCB.06410-11","article-title":"Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species\/Src\/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway","volume":"32","author":"Chen","year":"2012","journal-title":"Mol Cell Biol"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/69\/11\/2446\/433328\/db200579.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/69\/11\/2446\/433328\/db200579.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T08:44:06Z","timestamp":1696581846000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/69\/11\/2446\/39719\/YAP-Activation-in-Renal-Proximal-Tubule-Cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":65,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,8,25]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db20-0579","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]}}}